Trials / Completed
CompletedNCT05127707
Strategies to Reduce Addiction Stigma Among Health Professionals
Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Professionals: A Randomized Experiment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,842 (actual)
- Sponsor
- Johns Hopkins Bloomberg School of Public Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.
Detailed description
This randomized experiment evaluated the impact of exposure to message frames communicating the importance of non-stigmatizing language regarding addiction and the effectiveness of medication treatment for opioid use disorder delivered through a visual campaign alone or through a visual campaign in addition to a narrative vignette from the perspective of one of three messengers (a person with opioid use disorder, a clinician, or a health system leader) on attitudes toward people with opioid use disorder and medications for treating opioid use disorder among a national sample of health professionals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Words Matter - Visual Campaign | Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings. |
| BEHAVIORAL | Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician) | Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a person with opioid use disorder |
| BEHAVIORAL | Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician) | Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a clinician working with patients with opioid use disorder |
| BEHAVIORAL | Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator) | Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a health system administrator/leader |
| BEHAVIORAL | Medication Treatment for Opioid Use Disorder Works - Visual Campaign | Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives |
| BEHAVIORAL | Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) | Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a person with opioid use disorder |
| BEHAVIORAL | Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Clinician) | Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a clinician who treats people with opioid use disorder |
| BEHAVIORAL | Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator) | Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a health system administrator/leader |
Timeline
- Start date
- 2020-11-13
- Primary completion
- 2020-11-30
- Completion
- 2020-11-30
- First posted
- 2021-11-19
- Last updated
- 2021-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05127707. Inclusion in this directory is not an endorsement.